Tuberculous optochiasmatic arachnoiditis: a devastating form of tuberculous meningitis

Ravindra Kumar Garg1, Vimal Paliwal, Hardeep Singh Malhotra

  • 1Department of Neurology, Chhatrapati Shahuji Maharaj Medical University, Uttar Pradesh Lucknow, India. garg50@yahoo.com

Insights

Optochiasmatic arachnoiditis and tuberculoma are severe forms of tuberculous meningitis, often causing vision loss, particularly in young adults. Management remains challenging, with variable treatment responses and controversial outcomes.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Ophthalmology

Background:

  • Tuberculous meningitis (TBM) affects the brain and spinal cord meninges, characterized by inflammation, basal exudates, vasculitis, and hydrocephalus.
  • Optochiasmatic arachnoiditis and tuberculoma are severe TBM complications, predominantly impacting the basal brain structures and frequently leading to profound vision loss, especially in young adults.

Purpose of the Study:

  • To review the clinical presentation, predictors, and management strategies for optochiasmatic arachnoiditis and tuberculoma in tuberculous meningitis.
  • To highlight the therapeutic challenges and prognostic implications of these specific TBM manifestations.

Main Methods:

  • The study reviews existing literature and clinical data on tuberculous optochiasmatic arachnoiditis and tuberculoma.
  • Analysis includes identification of predictors for optochiasmatic arachnoiditis and evaluation of various treatment modalities.

Main Results:

  • Female sex, younger age, and elevated cerebrospinal fluid protein are predictors for optochiasmatic arachnoiditis.
  • These conditions can paradoxically develop during anti-TB treatment, presenting as enhancing lesions on MRI.
  • Management strategies, including corticosteroids and neurosurgery, show variable success and controversy.

Conclusions:

  • Optochiasmatic arachnoiditis and tuberculoma significantly impact the prognosis and treatment of TBM.
  • Effective management remains a challenge, often requiring a combination of anti-TB drugs and corticosteroids, with neurosurgery reserved for specific cases.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: